Koers BrightGene Bio-Medical Technology Co., Ltd.
Aandelen
688166
CNE100003PR1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
28,52 CNY | +4,51% | +9,57% | -18,51% |
Omzet 2021 | 1,05 mld. 145 mln. 135 mln. | Omzet 2022 | 1,02 mld. 140 mln. 131 mln. | Marktkapitalisatie | 9,54 mld. 1,32 mld. 1,23 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 244 mln. 33,67 mln. 31,41 mln. | Nettowinst (verlies) 2022 | 240 mln. 33,12 mln. 30,9 mln. | EV/omzet 2021 | 14,8 x |
Nettoschuld 2021 | 565 mln. 77,95 mln. 72,71 mln. | Nettoschuld 2022 | 791 mln. 109 mln. 102 mln. | EV/omzet 2022 | 10,2 x |
K/w-verhouding 2021 |
61,2
x | K/w-verhouding 2022 |
38,9
x | Werknemers | 1.128 |
Dividendrendement 2021 |
0,33% | Dividendrendement 2022 |
0,51% | Vrij verhandelbaar | 48,25% |
1 dag | +4,51% | ||
1 week | +9,57% | ||
Lopende maand | -2,60% | ||
1 maand | -4,36% | ||
3 maanden | +2,15% | ||
6 maanden | -31,13% | ||
Lopend jaar | -18,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 26-10-01 |
Yuan Lai Zou
DFI | Director of Finance/CFO | 53 | 01-01-11 |
Fan Hang
BRD | Director/Board Member | 38 | 01-01-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 26-10-01 |
Simon Lü
BRD | Director/Board Member | 56 | 13-05-17 |
Yang Qing Huang
BRD | Director/Board Member | 43 | 01-01-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 28,52 | +4,51% | 11 525 650 |
24-04-24 | 27,29 | +3,18% | 5 395 480 |
23-04-24 | 26,45 | +2,60% | 4 992 646 |
22-04-24 | 25,78 | +0,43% | 5 333 783 |
19-04-24 | 25,67 | -1,38% | 5 169 845 |
slotkoers Shanghai S.E., 25 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,51% | 1,59 mld. | |
+24,17% | 562 mld. | |
-6,33% | 358 mld. | |
+19,90% | 322 mld. | |
+7,95% | 297 mld. | |
+13,45% | 219 mld. | |
+6,04% | 199 mld. | |
-10,51% | 196 mld. | |
-12,26% | 149 mld. | |
-6,47% | 146 mld. |